Activation of the peroxisome proliferator-activated receptor gamma (PPARγ) improves insulin sensitivity and lowers circulating levels of glucose, triglycerides and free fatty acids without stimulating insulin secretion in rodent models of T2D [1,2]. Here, PPARG is linked to type 2 diabetes mellitus.